| Interest of youth living with HIV in long-acting antiretrovirals ED Weld, MS Rana, RH Dallas, AF Camacho-Gonzalez, P Ryscavage, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 80 (2), 190-197, 2019 | 61 | 2019 |
| Long-acting implants to treat and prevent HIV infection ED Weld, C Flexner Current Opinion in HIV and AIDS 15 (1), 33-41, 2020 | 53 | 2020 |
| Conceptual design of a universal donor screening approach for vaginal microbiota transplant K DeLong, S Bensouda, F Zulfiqar, HC Zierden, TM Hoang, AG Abraham, ... Frontiers in cellular and infection microbiology 9, 472788, 2019 | 44 | 2019 |
| Current status of pharmacokinetic and safety studies of multidrug-resistant tuberculosis treatment in children AJ Garcia-Prats, EM Svensson, ED Weld, HS Schaaf, AC Hesseling The International Journal of Tuberculosis and Lung Disease 22 (5), S15-S23, 2018 | 42 | 2018 |
| Antigen-specific IgA B memory cell responses to Shigella antigens elicited in volunteers immunized with live attenuated Shigella flexneri 2a oral vaccine candidates JK Simon, M Maciel Jr, ED Weld, R Wahid, MF Pasetti, WL Picking, ... Clinical Immunology 139 (2), 185-192, 2011 | 42 | 2011 |
| Ethical issues in therapeutic use and research in pregnant and breastfeeding women ED Weld, TC Bailey, C Waitt British journal of clinical pharmacology 88 (1), 7-21, 2022 | 36 | 2022 |
| Multiparametric magnetic resonance imaging to characterize cabotegravir long‐acting formulation depot kinetics in healthy adult volunteers BM Jucker, EJ Fuchs, S Lee, V Damian, P Galette, R Janiczek, KJ Macura, ... British Journal of Clinical Pharmacology 88 (4), 1655-1666, 2022 | 22 | 2022 |
| State‐of‐the‐art review of HIV‐TB coinfection in special populations ED Weld, KE Dooley Clinical Pharmacology & Therapeutics 104 (6), 1098-1109, 2018 | 19 | 2018 |
| Multicompartmental pharmacokinetic evaluation of long‐acting cabotegravir in healthy adults for HIV preexposure prophylaxis JS Shaik, ED Weld, S Edick, E Fuchs, S Riddler, MA Marzinke, R D'Amico, ... British journal of clinical pharmacology 88 (4), 1667-1678, 2022 | 17 | 2022 |
| A comparative pre-phase I study of the impact of gel vehicle volume on distal colon distribution, user experience, and acceptability ED Weld, H Hiruy, KM Guthrie, JL Fava, SE Vargas, K Buckheit, ... AIDS research and human retroviruses 33 (5), 440-447, 2017 | 14 | 2017 |
| Twice neglected? Neglected diseases in neglected populations ED Weld, C Waitt, K Barnes, F Garcia Bournissen British journal of clinical pharmacology 88 (2), 367-373, 2022 | 11 | 2022 |
| Limits of detection and limits of infection: quantitative HIV measurement in the era of U= U ED Weld The journal of applied laboratory medicine 6 (1), 324-326, 2021 | 9 | 2021 |
| Realizing the promise of long-acting antiretroviral treatment strategies for individuals with HIV and adherence challenges: an illustrative case series C Kilcrease, H Yusuf, J Park, A Powell, LJ Rn, JO Rn, BD Lmsw, ED Weld, ... AIDS research and therapy 19 (1), 56, 2022 | 8 | 2022 |
| Examining the safety, pharmacokinetics, and pharmacodynamics of a rectally administered IQP-0528 gel for HIV pre-exposure prophylaxis: a first-in-human study A Al-Khouja, E Shieh, EJ Fuchs, MA Marzinke, RP Bakshi, P Hummert, ... AIDS research and human retroviruses 37 (6), 444-452, 2021 | 8 | 2021 |
| Lubricant provides poor rectal mucosal HIV coverage EC Shieh, ED Weld, EJ Fuchs, H Hiruy, KW Buckheit, RW Buckheit Jr, ... AIDS research and human retroviruses 33 (8), 784-787, 2017 | 8 | 2017 |
| The expanding range and severity of babesiosis ED Weld, KM Eimer, K Saharia, A Orenstein, JR Hess Transfusion 2 (50), 290-291, 2010 | 8 | 2010 |
| Preferences of persons with or at risk for hepatitis C for long-acting treatments ED Weld, J Astemborski, GD Kirk, MS Sulkowski, S Katz, R Rothman, ... Clinical Infectious Diseases 75 (1), 3-10, 2022 | 7 | 2022 |
| Tenofovir douche for PrEP: on-demand, behaviorally-congruent douche rapidly achieves colon tissue concentration targets (DREAM 01 Study) E Weld, E Fuchs, M Marzinke, P Anton, K Ho, R Bakshi, J Engstrom, ... AIDS RESEARCH AND HUMAN RETROVIRUSES 34, 71-71, 2018 | 7 | 2018 |
| Conducting efficacy trials in children with MDR-TB: what is the rationale and how should they be done? JA Seddon, ED Weld, HS Schaaf, AJ Garcia-Prats, S Kim, AC Hesseling The International Journal of Tuberculosis and Lung Disease 22 (5), S24-S33, 2018 | 7 | 2018 |
| The time has come: sparing injectables in paediatric MDR-TB ED Weld, AJ Garcia-Prats, JJ Furin, TC Bailey, AC Hesseling, KE Dooley The Lancet Respiratory Medicine 5 (4), 245-246, 2017 | 7 | 2017 |
